NO923429D0 - Vandig oppslemmingspreparat for injeksjon, fremgangsmaate til aa produsere samme og bruk av samme for aa frembringe smertelindring - Google Patents

Vandig oppslemmingspreparat for injeksjon, fremgangsmaate til aa produsere samme og bruk av samme for aa frembringe smertelindring

Info

Publication number
NO923429D0
NO923429D0 NO1992923429A NO923429A NO923429D0 NO 923429 D0 NO923429 D0 NO 923429D0 NO 1992923429 A NO1992923429 A NO 1992923429A NO 923429 A NO923429 A NO 923429A NO 923429 D0 NO923429 D0 NO 923429D0
Authority
NO
Norway
Prior art keywords
same
preparation
less
injection
producers
Prior art date
Application number
NO1992923429A
Other languages
English (en)
Other versions
NO300114B1 (no
NO923429L (no
Inventor
Eric Willem Ackerman
Rene Jacobus Elisabert Grouls
Hendrikus Korsten
Original Assignee
Catharina Ziekenhuis Stichting
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catharina Ziekenhuis Stichting filed Critical Catharina Ziekenhuis Stichting
Publication of NO923429D0 publication Critical patent/NO923429D0/no
Publication of NO923429L publication Critical patent/NO923429L/no
Publication of NO300114B1 publication Critical patent/NO300114B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO923429A 1990-03-20 1992-09-03 Fremgangsmåte for fremstilling av et vandig suspensjonspreparat for injeksjon NO300114B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9000634A NL9000634A (nl) 1990-03-20 1990-03-20 Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
PCT/NL1991/000042 WO1991014455A1 (en) 1990-03-20 1991-03-20 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief

Publications (3)

Publication Number Publication Date
NO923429D0 true NO923429D0 (no) 1992-09-03
NO923429L NO923429L (no) 1992-09-17
NO300114B1 NO300114B1 (no) 1997-04-14

Family

ID=19856770

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923429A NO300114B1 (no) 1990-03-20 1992-09-03 Fremgangsmåte for fremstilling av et vandig suspensjonspreparat for injeksjon

Country Status (15)

Country Link
US (1) US5346903A (no)
EP (1) EP0521070B1 (no)
JP (1) JPH05507466A (no)
AT (1) ATE121631T1 (no)
AU (1) AU646857B2 (no)
BR (1) BR1100601A (no)
CA (1) CA2077641C (no)
DE (1) DE69109279T2 (no)
DK (1) DK0521070T3 (no)
ES (1) ES2074269T3 (no)
FI (1) FI98890C (no)
GR (1) GR3015940T3 (no)
NL (1) NL9000634A (no)
NO (1) NO300114B1 (no)
WO (1) WO1991014455A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206267A (en) * 1991-05-09 1993-04-27 Morton Shulman Pain controlling composition and method of preparation
US5635540A (en) * 1994-12-09 1997-06-03 The University Of Virginia Patent Foundation Stabilized topical pharmaceutical preparations
US6077545A (en) 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
ES2341399T3 (es) * 1996-03-26 2010-06-18 Eli Lilly And Company Benziotofenos, formulaciones que contienen los mismos y procedimientos.
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
JP2004527573A (ja) * 2001-04-24 2004-09-09 パーデュー・リサーチ・ファウンデーション 哺乳類の神経組織損傷の治療のための方法及び組成物
AU2003211009A1 (en) * 2002-02-11 2003-09-04 Wake Forest University Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
US7838034B2 (en) 2002-07-30 2010-11-23 Grunenthal Gmbh Intravenous pharmaceutical form of administration
DE10234784A1 (de) * 2002-07-30 2004-02-19 Günenthal GmbH Intravenös applizierbare, pharmazeutische Darreichungsform
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
JP4686361B2 (ja) * 2002-12-31 2011-05-25 アルタス ファーマシューティカルズ インコーポレイテッド ヒト成長ホルモンの結晶およびその調製方法
WO2004060920A1 (en) * 2002-12-31 2004-07-22 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
WO2007076131A2 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
JP2010513309A (ja) * 2006-12-18 2010-04-30 アルタス ファーマシューティカルズ インコーポレイテッド ヒト成長ホルモン製剤
FI20075091A0 (fi) * 2007-02-09 2007-02-09 Kim Lemberg Noroksimorfoni käytettäväksi lääkeaineena
US20080227805A1 (en) * 2007-02-28 2008-09-18 Abbott Laboratories Sustained release parenteral formulations of buprenorphine
US9125867B2 (en) * 2010-02-24 2015-09-08 Invincible Biotechnology Diversion- and/or abuse-resistant compositions and methods for making the same
GB2513060B (en) * 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
AU2015341490C1 (en) 2014-11-07 2021-03-11 Indivior Uk Limited Buprenorphine dosing regimens
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
WO2022175977A1 (en) * 2021-02-18 2022-08-25 Navin Saxena Research And Technology Private Limited A biodegradable implant composition and process for long term delivery of buprenorphine and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB784659A (en) * 1954-11-26 1957-10-16 Upjohn Co Therapeutic compositions and aqueous suspensions thereof
US3337406A (en) * 1963-12-12 1967-08-22 Mar Sal Inc Treatment of arteriosclerotic diseases
EP0031603A1 (en) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmaceutical composition of matter
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4599354A (en) * 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief

Also Published As

Publication number Publication date
BR1100601A (pt) 2000-04-18
NO300114B1 (no) 1997-04-14
NO923429L (no) 1992-09-17
CA2077641C (en) 2001-07-03
JPH05507466A (ja) 1993-10-28
AU646857B2 (en) 1994-03-10
FI98890B (fi) 1997-05-30
EP0521070B1 (en) 1995-04-26
CA2077641A1 (en) 1991-09-21
WO1991014455A1 (en) 1991-10-03
FI924019A0 (fi) 1992-09-08
DE69109279D1 (de) 1995-06-01
ATE121631T1 (de) 1995-05-15
AU7558091A (en) 1991-10-21
FI924019A (fi) 1992-09-08
NL9000634A (nl) 1991-10-16
GR3015940T3 (en) 1995-07-31
US5346903A (en) 1994-09-13
EP0521070A1 (en) 1993-01-07
FI98890C (fi) 1997-09-10
DE69109279T2 (de) 1995-11-09
DK0521070T3 (da) 1995-05-22
ES2074269T3 (es) 1995-09-01

Similar Documents

Publication Publication Date Title
NO923429D0 (no) Vandig oppslemmingspreparat for injeksjon, fremgangsmaate til aa produsere samme og bruk av samme for aa frembringe smertelindring
ZA959386B (en) Small particle formation
JPS55147228A (en) Fat emulsion for intravenous injection
NO971792L (no) Blanding inneholdende en aerogel, dens fremstilling og anvendelse
DE69218241D1 (de) Arzneistofformulierung zur parenteralen anwendung
PT98272A (pt) Processo para a preparacao de uma composicao farmaceutica para suspensao rapida em agua
ATE150310T1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
FR2695558B1 (fr) Composition cosmétique contenant des particules solides revêtues avec un polymère amphotère.
ATE206067T1 (de) Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe
DE59509430D1 (de) Wärmeträgerkonzentrat, verfahren zu dessen herstellung sowie dessen verwendung und latentwärmespeicher
HUP9904360A2 (hu) Eljárás emesis és központi idegrendszeri rendellenességek kezelésére, optikailag tiszta (+)-norciszaprid alkalmazásával
KR950701223A (ko) 항허혈성(Anti-ichemic)약물
Fingeret The illiterate underclass: Demythologizing an American stigma
KR900007319A (ko) 살충 조성물
PL308838A1 (en) Pharmaceutical preparation containing cefixim as its active substance and method of stabilising such preparations
EP0135189A3 (en) Pharmaceutically useful malonamides
DaVanzo et al. Studies on the mechanism of action of aminooxyacetic acid: I. Reversal of aminooxyacetic acid-induced convulsions by various agents
ES8506338A1 (es) Procedimiento de intensificar cultivos agricolas y similares
Rubin Too much of nothing: modern culture, the self and salvation in Kierkegaard's thought
Marshall et al. Spontaneous morphine withdrawal from the rat spinal cord
CA1038761A (en) Composition for controlling sexual behavior of mammals
Guilloteau et al. MIBG and catecholamine storage in the brain: an in-vitro study
JPS6483015A (en) Drug-containing fluorinated hydrocarbon emulsion and production thereof
Peterson et al. Acute inhibition of microsomal drug metabolism by propoxyphene in narcotic tolerant/dependent mice
Parellada et al. Local anaesthetics imidazole and calcium